Committee to examine Pentavalent vaccine’s safety
In the wake of 21 infants dying after receiving Pentavalent vaccine in the country, the government will conduct a study to ascertain its safety.
The government will soon set up a national-level Adverse Events Following Immunisation (AEFI) Committee that will launch a study on the safety and effectiveness of Pentavalent vaccine and will go into background of the deaths of 21 infants who received this vaccine in various states of India. The proposed study will be conducted with the help of some other agencies and the WHO will also be involved in it.
What is a Pentavalent Vaccine?
The Pentavalent vaccine protects children against five deadly childhood diseases — DPT (Diphtheria, Pertussis and Tetanus), Hepatitis B and Haemophilus influenza type B (HiB).
Categories: Science and Technology Current Affairs - 2017